| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phio Pharmaceuticals Corp. (PHIO) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. PHIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 411.4K | $534.8K | - | |
| CFO | 94.0K | $122.2K | - | |
| Dir | 45.7K | $59.3K | - | |
| Dir | 38.7K | $50.3K | - | |
| Dir | 37.8K | $49.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | Bitterman Robert J | President &CEO | Buy | 1,000 | $0.75 | $750.00 | +5.3% | |
| Feb 26, 2024 | Bitterman Robert J | President &CEO | Buy | 2,500 | $0.91 | $2,275.00 | +15.2% | |
| Jul 1, 2023 | Bitterman Robert J | President &CEO | Buy | 2,000 | $2.86 | $5,720.00 | +5.6% | |
| Jun 14, 2023 | Ferrara Robert L | Director | Buy | 2,000 | $3.10 | $6,200.00 | +50.0% | |
| Dec 14, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | +2.8% | |
| Dec 7, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.39 | $780.00 | +2.8% | |
| Dec 5, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,000 | $0.43 | $860.00 | +2.9% | |
| Dec 2, 2022 | Ferrara Robert L | Director | Buy | 5,000 | $0.41 | $2,041.00 | +20.0% | |
| Nov 29, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 2,715 | $0.42 | $1,136.00 | +2.0% | |
| Nov 23, 2022 | Ferrara Robert L | Director | Buy | 2,000 | $0.41 | $819.80 | +8.7% |